All stock lists
Incyte Corp (NASDAQ:INCY)
US · Delayed Price · Currency is USD
Also listed: 0J9P.LHealthcare · Biotechnology
113.25-2.46 (-2.12%)
Insider Score
––Not scored
INCY Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
INCY Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.67 B | 1.27 B | 1.51 B | 1.37 B | 1.22 B | 1.05 B |
| Revenue Growth (YoY) | 37.72 % | 20.87 % | 27.84 % | 20.05 % | 16.46 % | 19.53 % |
| Cost of Revenue | 104.96 M | 104.50 M | 121.10 M | 99.00 M | 78.80 M | 73.20 M |
| Gross Profit | 1.57 B | 1.17 B | 1.39 B | 1.27 B | 1.14 B | 979.70 M |
| SG&A Expense | 351.74 M | 328.10 M | 390.40 M | 329.10 M | 331.00 M | 325.70 M |
| R&D Expense | 516.95 M | 515.90 M | 611.37 M | 506.58 M | 494.92 M | 437.28 M |
| Operating Expenses | 871.18 M | 844.00 M | 1.00 B | 835.68 M | 825.92 M | 762.98 M |
| Operating Income | 697.90 M | 324.17 M | 383.96 M | 431.30 M | 310.81 M | 216.72 M |
| Pretax Income | 751.51 M | 343.60 M | 389.94 M | 482.31 M | 558.01 M | 234.19 M |
| Tax Provision | 165.91 M | 40.27 M | 90.66 M | 58.14 M | 153.01 M | 75.99 M |
| Net Income | 585.61 M | 303.33 M | 299.28 M | 424.17 M | 405.00 M | 158.20 M |
| EPS (Basic) | 2.92 | 1.52 | 1.52 | 2.17 | 2.09 | 0.82 |
| EPS (Diluted) | 2.81 | 1.47 | 1.46 | 2.11 | 2.04 | 0.80 |
| Shares Outstanding | 200.38 M | 199.34 M | 197.44 M | 195.67 M | 194.00 M | 193.71 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.